Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy

Ovarian cancer is a highly fatal gynecologic malignancy worldwide. Chemotherapy remains the primary modality both for primary and maintenance treatments of ovarian cancer. However, the progress in developing chemotherapeutic agents for ovarian cancer has been slow in the past 20 years. Thus, new and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guang, Ling, Mingjian, Yu, Kunyi, Yang, Wei, Liu, Qiwen, He, Lijuan, Cai, Xuzi, Zhong, Min, Mai, Ziyi, Sun, Rui, Xiao, Yuanling, Yu, Zhiqiang, Wang, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636721/
https://www.ncbi.nlm.nih.gov/pubmed/36335352
http://dx.doi.org/10.1186/s12951-022-01676-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636721/
https://www.ncbi.nlm.nih.gov/pubmed/36335352
http://dx.doi.org/10.1186/s12951-022-01676-3

Ejemplares similares